secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001104659-25-004565
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio effects 1-for-50 reverse stock split to regain Nasdaq compliance
----------------------------------------------------------------------------

- Outstanding shares reduced from ~64.8M to ~1.3M; split effective Jan 15, 2025.
- Trading on split-adjusted basis under symbol MBIO begins Jan 16, 2025.
- Reverse split intended to meet Nasdaq's $1.00 minimum bid price requirement.
- No fractional shares issued; cash payment in lieu for fractional entitlements.
- New CUSIP 62818Q302; board set final ratio on Jan 6, 2025 per prior stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925004565/0001104659-25-004565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925004565/tm253736d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-004565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer